Faraday Future Secures $105 Million in Financing to Fund the Company’s Aggressive Growth Strategy, Launch of the FX Super One and Advancement of the Company’s Position in the AIEV Market

July 17, 2025

Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach

FY25 revenue up 14.3% YOY FY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continue FY25 operating expenses lower by 24.5% YOY Negative EBITDA reduced by $5.7 million to $3.2 million – an improvement of 63.9% Positive Adjusted EBITDA of $438,260 […]

July 17, 2025

Lantern Pharma Unveils Groundbreaking AI-Powered Module to Predict Activity and Efficacy of Combination Regimens in Clinical Cancer Treatment

The AI module, trained on 221 clinical trials, will be incorporated as part of Lantern’s AI platform, RADR ®, and will initially focus on tailored combinations of DNA damaging agents and DNA repair inhibitors Addresses $50+ billion combination cancer therapy market projected to grow 8.5% annually through 2030 Over 60% of cancer patients received DNA damaging […]

July 15, 2025

Faraday Future Secures $105 Million in Financing to Fund the Company’s Aggressive Growth Strategy, Launch of the FX Super One and Advancement of the Company’s Position in the AIEV Market

The Company expects that it will have sufficient capital to launch its new product, FX Super One and accelerate development and distribution efforts for its FF and FX brands and AI-related technologies. LOS ANGELES–(BUSINESS WIRE)–Jul. 16, 2025– Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem […]

July 16, 2025